[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), and Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast up to 2027

July 2023 | 226 pages | ID: S3FD15357DB0EN
IHR Insights

US$ 4,500.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The spirulina market refers to the market for the blue-green algae known as spirulina. Spirulina is a natural dietary supplement that is widely recognized for its nutritional value and potential health benefits. It is a rich source of protein, vitamins, minerals, antioxidants, and other bioactive compounds. The rising awareness about the health benefits of spirulina has been a major driver for its market growth. Spirulina is rich in essential nutrients, vitamins, minerals, and antioxidants, making it a popular choice among health-conscious consumers. Its potential benefits in boosting immunity, improving digestion, and supporting weight management have fueled demand for spirulina. On the other hand, the possibility of contamination may limit the spirulina market growth. Spirulina Market is likely to grow at a rate of 4.8% CAGR by 2027.

Spirulina Market by Type

Arthrospira Platensis
Arthrospira Maxima

Spirulina Market by Application

Nutraceuticals
Food & Beverages
Cosmetics
Animal Feed

Spirulina Market by Route Formulation

Powder
Tablet & Capsule
Liquid
Granule & Gelling Agent

Spirulina Market by Geography

North America
Europe
Asia Pacific
Rest of the World

Here is an overview of the key aspects of the spirulina market:

Nutritional Supplement: Spirulina is often consumed as a nutritional supplement due to its high nutritional content. It is particularly known for its protein content, which makes it a popular choice among vegetarians and vegans as a plant-based protein source. Spirulina also contains essential amino acids, vitamins (such as B vitamins and vitamin K), minerals (including iron, magnesium, and calcium), and antioxidants (such as phycocyanin and beta-carotene).

Health Benefits: Spirulina is believed to offer several health benefits. It may help boost the immune system, support heart health by reducing cholesterol levels, and provide anti-inflammatory and antioxidant effects. Spirulina has also been studied for its potential role in weight management, improving gut health, and supporting healthy blood sugar levels. However, further research is needed to fully understand its effects and mechanisms of action.

Forms and Products: Spirulina is available in various forms, including powder, tablets, capsules, and flakes. It can be consumed on its own or incorporated into smoothies, juices, and food products. Spirulina is used in the production of dietary supplements, functional foods, beverages, and animal feed.

Cultivation and Production: Spirulina is cultivated in freshwater or saltwater environments. It is typically grown in large-scale commercial facilities or in controlled conditions such as ponds or tanks. The production of spirulina involves cultivating the algae, harvesting, drying, and processing it into the desired form for consumption or further use.

Market Growth: The spirulina market has experienced significant growth in recent years, driven by increasing consumer awareness of its nutritional benefits and growing demand for natural and plant-based ingredients. The rising popularity of vegetarian and vegan diets, as well as the increasing focus on health and wellness, has contributed to the market's expansion. Spirulina is also gaining attention as a sustainable protein source with a lower environmental footprint compared to traditional livestock production.

Regulations and Quality Control: Due to the increasing demand for spirulina, regulatory authorities have established standards and guidelines to ensure product safety and quality. It is important for manufacturers to comply with these regulations and follow good manufacturing practices to maintain the integrity and purity of spirulina products.

The major leading companies of the spirulina market are Algenol Biofuels Inc., Cabassi & Giuriati Spa, Cyanotech Corporation, Ddw Inc., Dic Corporation, Dцhler Gmbh, Dongtai City Spirulina Bio-Engineering Co, Ltd., Echlorial, E.I.D. Parry Limited, Givaudan International Sa, Prolgae Spirulina Supplies Pvt. Ltd., Pond Technologies Inc., Sensient Technologies Corporation

The market is highly competitive, with companies focusing on product quality, innovation, and marketing strategies to capture the growing consumer demand.

It's worth noting that while spirulina is generally considered safe for most individuals, it may not be suitable for everyone. It is recommended to consult with a healthcare professional before starting any new dietary supplements or making significant changes to your diet.

An exclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
Detailed information about the attributes which are generating growth in the spirulina market in the forecast period.
An exact estimation of the spirulina market share and its contribution to the parent market is provided in the report.
Further profiles of leading competitors and their dynamic strategies are also covered in the study.
1. EXECUTIVE SUMMARY

2. INDUSTRY OUTLOOK

2.1. Industry Overview
2.2. Industry Trends

3. MARKET SNAPSHOT

3.1. Market Definition
3.2. Market Outlook
  3.2.1. Porter Five Forces
3.3. Related Markets

4. MARKET CHARACTERISTICS

4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. TYPE: MARKET SIZE & ANALYSIS

5.1. Overview
5.2. Arthrospira Platensis
5.3. Arthrospira Maxima

6. APPLICATION: MARKET SIZE & ANALYSIS

6.1. Overview
6.2. Nutraceuticals
6.3. Food & Beverages
6.4. Cosmetics
6.5. Animal Feed

7. DISTRIBUTION CHANNEL: MARKET SIZE & ANALYSIS

7.1. Overview
7.2. Hospital Pharmacies
7.3. Online Providers
7.4. Drug Stores and Retail Pharmacies

8. GEOGRAPHY: MARKET SIZE & ANALYSIS

8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. COMPETITIVE LANDSCAPE

9.1. Competitor Comparison Analysis
9.2. Market Developments
  9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
  9.2.2. Product Launches and execution

10. VENDOR PROFILES

10.1. Algenol Biofuels Inc.
  10.1.1. Overview
  10.1.2. Financial Overview
  10.1.3. Product Offerings
  10.1.4. Developments
  10.1.5. Business Strategy
10.2. Cabassi & Giuriati Spa
  10.2.1. Overview
  10.2.2. Financial Overview
  10.2.3. Product Offerings
  10.2.4. Developments
  10.2.5. Business Strategy
10.3. Cyanotech Corporation
  10.3.1. Overview
  10.3.2. Financial Overview
  10.3.3. Product Offerings
  10.3.4. Developments
  10.3.5. Business Strategy
10.4. Ddw Inc.
  10.4.1. Overview
  10.4.2. Financial Overview
  10.4.3. Product Offerings
  10.4.4. Developments
  10.4.5. Business Strategy
10.5. Dic Corporation
  10.5.1. Overview
  10.5.2. Financial Overview
  10.5.3. Product Offerings
  10.5.4. Developments
  10.5.5. Business Strategy
10.6. Dцhler Gmbh
  10.6.1. Overview
  10.6.2. Financial Overview
  10.6.3. Product Offerings
  10.6.4. Developments
  10.6.5. Business Strategy
10.7. Dongtai City Spirulina Bio-Engineering Co, Ltd.
  10.7.1. Overview
  10.7.2. Financial Overview
  10.7.3. Product Offerings
  10.7.4. Developments
  10.7.5. Business Strategy
10.8. Echlorial
  10.8.1. Overview
  10.8.2. Financial Overview
  10.8.3. Product Offerings
  10.8.4. Developments
  10.8.5. Business Strategy
10.9. E.I.D. Parry Limited
  10.9.1. Overview
  10.9.2. Financial Overview
  10.9.3. Product Offerings
  10.9.4. Developments
  10.9.5. Business Strategy
10.10. Givaudan International Sa
  10.10.1. Overview
  10.10.2. Financial Overview
  10.10.3. Product Offerings
  10.10.4. Developments
  10.10.5. Business Strategy
10.11. Prolgae Spirulina Supplies Pvt. Ltd.
  10.11.1. Overview
  10.11.2. Financial Overview
  10.11.3. Product Offerings
  10.11.4. Developments
  10.11.5. Business Strategy
10.12. Pond Technologies Inc.
  10.12.1. Overview
  10.12.2. Financial Overview
  10.12.3. Product Offerings
  10.12.4. Developments
  10.12.5. Business Strategy
10.13. Sensient Technologies Corporation
  10.13.1. Overview
  10.13.2. Financial Overview
  10.13.3. Product Offerings
  10.13.4. Developments
  10.13.5. Business Strategy

11. ANALYST OPINION

12. ANNEXURE

12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
  12.3.1. Data Collation and In-house Estimation
  12.3.2. Market Triangulation
  12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations


LIST OF TABLES

TABLE 1. GLOBAL SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA PLATENSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA MAXIMA, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL SPIRULINA MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL SPIRULINA MARKET VALUE FOR NUTRACEUTICALS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL SPIRULINA MARKET VALUE FOR FOOD & BEVERAGES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL SPIRULINA MARKET VALUE FOR COSMETICS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL SPIRULINA MARKET VALUE FOR ANIMAL FEED, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL SPIRULINA MARKET VALUE FOR POWDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL SPIRULINA MARKET VALUE FOR TABLET & CAPSULE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL SPIRULINA MARKET VALUE FOR LIQUID, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL SPIRULINA MARKET VALUE FOR GRANULE & GELLING AGENT, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. NORTH AMERICA SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 18. U.S SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 19. U.S SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 20. U.S SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 21. CANADA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 22. CANADA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 23. CANADA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 24. EUROPE SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 25. EUROPE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 26. EUROPE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 27. EUROPE SPIRULINA MARKET VALUE, ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 28. GERMANY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 29. GERMANY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 30. GERMANY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 31. U.K SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 32. U.K SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 33. U.K SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 34. FRANCE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 35. FRANCE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 36. FRANCE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 37. ITALY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 38. ITALY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 39. ITALY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 40. SPAIN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 41. SPAIN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 42. SPAIN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 43. ROE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 44. ROE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 45. ROE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 46. ASIA PACIFC SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 49. ASIA PACIFC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 50. CHINA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 51. CHINA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 52. CHINA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 53. INDIA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 54. INDIA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 55. INDIA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 56. JAPAN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 57. JAPAN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 58. JAPAN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 59. REST OF APAC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 61. REST OF APAC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 62. REST OF WORLD SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 64. REST OF WORLD SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION)
TABLE 65. ALGENOL BIOFUELS INC.: FINANCIALS
TABLE 66. ALGENOL BIOFUELS INC.: PRODUCTS & SERVICES
TABLE 67. ALGENOL BIOFUELS INC.: RECENT DEVELOPMENTS
TABLE 68. CABASSI & GIURIATI SPA: FINANCIALS
TABLE 69. CABASSI & GIURIATI SPA: PRODUCTS & SERVICES
TABLE 70. CABASSI & GIURIATI SPA: RECENT DEVELOPMENTS
TABLE 71. CYANOTECH CORPORATION: FINANCIALS
TABLE 72. CYANOTECH CORPORATION: PRODUCTS & SERVICES
TABLE 73. CYANOTECH CORPORATION: RECENT DEVELOPMENTS
TABLE 74. DDW INC.: FINANCIALS
TABLE 75. DDW INC.: PRODUCTS & SERVICES
TABLE 76. DDW INC.: RECENT DEVELOPMENTS
TABLE 77. DIC CORPORATION: FINANCIALS
TABLE 78. DIC CORPORATION: PRODUCTS & SERVICES
TABLE 79. DIC CORPORATION: RECENT DEVELOPMENTS
TABLE 80. DЦHLER GMBH: FINANCIALS
TABLE 81. DЦHLER GMBH: PRODUCTS & SERVICES
TABLE 82. DЦHLER GMBH: RECENT DEVELOPMENTS
TABLE 83. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: FINANCIALS
TABLE 84. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: PRODUCTS & SERVICES
TABLE 85. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: RECENT DEVELOPMENTS
TABLE 86. ECHLORIAL: FINANCIALS
TABLE 87. ECHLORIAL: PRODUCTS & SERVICES
TABLE 88. ECHLORIAL: RECENT DEVELOPMENTS
TABLE 89. E.I.D. PARRY LIMITED: FINANCIALS
TABLE 90. E.I.D. PARRY LIMITED: PRODUCTS & SERVICES
TABLE 91. E.I.D. PARRY LIMITED: RECENT DEVELOPMENTS
TABLE 92. GIVAUDAN INTERNATIONAL SA: FINANCIALS
TABLE 93. GIVAUDAN INTERNATIONAL SA: PRODUCTS & SERVICES
TABLE 94. GIVAUDAN INTERNATIONAL SA: RECENT DEVELOPMENTS
TABLE 95. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: FINANCIALS
TABLE 96. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: PRODUCTS & SERVICES
TABLE 97. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: RECENT DEVELOPMENTS
TABLE 98. POND TECHNOLOGIES INC.: FINANCIALS
TABLE 99. POND TECHNOLOGIES INC.: PRODUCTS & SERVICES
TABLE 100. POND TECHNOLOGIES INC.: RECENT DEVELOPMENTS
TABLE 101. SENSIENT TECHNOLOGIES CORPORATION: FINANCIALS
TABLE 102. SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS & SERVICES
TABLE 103. SENSIENT TECHNOLOGIES CORPORATION: RECENT DEVELOPMENTS


More Publications